Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     General & Plastic Surgery    

Global Ablation Devices Market

Ablation Devices adds up major share to total General & Plastic Surgery market.
Ablation Devices can be segmented by Applications, Companies, MacroIndicators, Geographies, Technologies and Products. 

Geographies that Ablation Devices market covers, are North America, Europe and Asia. Technologies of Ablation Devices are Thermal Ablation and Non-thermal Ablation. The major players are Accuray Incorporated, Biosense Webster, Boston Scientific, CR Bard.

show more
PRODUCT TITLE PUBLISHED
Radiation Ablators Radiation Ablators
Radiation Ablators adds up considerable share to the total Ablation Devices market. Radiation Ablators can be segmented by Applications, Companies, MacroIndicators, Geographies and Products. Deep dive analysis of the key players of this domain, have been considered in this report.
Upcoming
Global Brachytherapy Market Global Brachytherapy Market
The global brachytherapy market was valued at  $450 Million in 2013.Peers of Brachytherapy are Stereotactic Radiosurgery & Stereotactic Radiotherapy and Image Guided Radiation Therapy (IGRT) comprising respectively of the Global Radiation Ablators market. The Market is segmented on basis of products, applications and technology. Deep dive analysis of the top players of this domain, have been considered in the report.  
Upcoming
Thermal Ablation Thermal Ablation
The Global Thermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery was pegged at $9386 million in 2013 and expected to be $15480 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
Non-thermal Ablation Non-thermal Ablation
Non-thermal Ablation and Thermal Ablation adds up to total Ablation...
Upcoming
Electrical Ablators Electrical Ablators
The global electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $785 million in 2013 and is expected to reach $1006 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
Upcoming
Microwave Ablation Microwave Ablation
The Global Microwave Ablation Market was pegged at $120 million in 2013 and expected to be $201 million by 2018. Microwave thermotherapy is the technology employed in Microwave Ablation. Currently there are very few players in microwave ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S).  
Upcoming
Ultrasound Ablation Ultrasound Ablation
The Global Ultrasound Ablation Market was pegged at $1243 million in 2013 and expected to be $2282 million by 2018. The key players in ultrasound ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix.
Upcoming
Cryoablation Cryoablation
Cryoablation and Hydromechanical Ablation adds up to total
Upcoming
Hydromechanical Ablation Hydromechanical Ablation
Hydromechanical Ablation and Cryoablation adds up to total
Upcoming
Argon Plasma/Beam coagulators Argon Plasma/Beam coagulators
Argon Plasma/Beam coagulators and Irreversible electroporation adds up to total
Upcoming
Irreversible electroporation Irreversible electroporation
Irreversible electroporation and Argon Plasma/Beam coagulators adds up to total
Upcoming
Stereotactic Radiosurgery & Stereotactic Radiotherapy Stereotactic Radiosurgery & Stereotactic Radiotherapy
Stereotactic Radiosurgery & Stereotactic Radiotherapy and Brachytherapy and
Upcoming
Image Guided Radiation Therapy (IGRT) Image Guided Radiation Therapy (IGRT)
Image Guided Radiation Therapy (IGRT) and Brachytherapy and
Upcoming
High-Dose-Rate (HDR) brachytherapy High-Dose-Rate (HDR) brachytherapy
High-Dose-Rate (HDR) brachytherapy and Pulsed-Dose-Rate brachytherapy and
Upcoming
Pulsed-Dose-Rate brachytherapy Pulsed-Dose-Rate brachytherapy
Pulsed-Dose-Rate brachytherapy and High-Dose-Rate (HDR) brachytherapy and
Upcoming
Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy
Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy and High-Dose-Rate (HDR) brachytherapy and
Upcoming
Electrical Ablation Electrical Ablation
The Global Electrical Ablation Market was pegged at $867 million in 2013 and expected to be $1098 million by 2018. In electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific (U.S), Angiodynamics (U.S), and Covidien (Ireland).
Upcoming
Hydrothermal Ablation Hydrothermal Ablation
The Global Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery. An endometrial hydrothermal balloon ablation device is the major technology indulged in hydrothermal ablation market. The main companies operating in hydrothermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
Light/Laser Ablation Light/Laser Ablation
The Global Light/Laser Ablation Market,  was pegged at $1183 million in 2013 and expected to be $1859 million by 2018. The light/laser ablation devices consist of two types of lasers namely, cold lasers and excimer lasers. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others.
Upcoming
Radiation Ablation Radiation Ablation
The Global Radiation Ablation Market was pegged at $3735 million in 2013 and expected to be $5537 million by 2018. In terms of volume, the stereotactic radiotherapy and radiosurgery devices accounted for the largest volume in sales.The main companies operating in this market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
51 reports | Show
Connect With Us
US/CAN : +1-888-502-0539